LOCALLY ADVANCED OR METASTATIC SOLID TUMOR
Clinical trials for LOCALLY ADVANCED OR METASTATIC SOLID TUMOR explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED OR METASTATIC SOLID TUMOR trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED OR METASTATIC SOLID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cancer drug enters first human trials
Disease control Recruiting nowThis is an early-stage study testing a new drug called BL-B01D1 for people with advanced solid tumors that have spread or cannot be cured with standard treatments. The main goals are to find the safest dose, check how the body processes the drug, and look for early signs that it …
Matched conditions: LOCALLY ADVANCED OR METASTATIC SOLID TUMOR
Phase: PHASE1 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New hope for tough cancers: early trial tests novel treatment
Disease control Recruiting nowThis is an early-stage study testing a new drug called BL-M07D1 for people with advanced breast cancer and other solid tumors that have spread or cannot be removed by surgery. The main goal is to find a safe dose and check for side effects in a small group of patients whose cance…
Matched conditions: LOCALLY ADVANCED OR METASTATIC SOLID TUMOR
Phase: PHASE1 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 11, 2026 14:54 UTC
-
Scientists track experimental cancer Drug's journey through the body
Knowledge-focused Recruiting nowThis early-stage study aims to understand how the body absorbs, processes, and eliminates the experimental drug Saruparib in patients with advanced solid tumors. Eight participants will stay in a hospital to receive the drug orally and intravenously while researchers collect bloo…
Matched conditions: LOCALLY ADVANCED OR METASTATIC SOLID TUMOR
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Apr 01, 2026 21:56 UTC